Clinical Trial Update: Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and toxicity of paclitaxel and cisplatin combined with sindilimab as neoadjuvant therapy for locally advanced cervical can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Sindilimab (Sindilimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Cervical Cancer, Chemotherapy Effect | Phase 2 | Status: COMPLETED